Stiripentol

Overview

Stiripentol is an anticonvulsant medication used to treat seizures in individuals with Dravet syndrome, a severe form of epilepsy. It works by stabilizing neuronal activity and has been shown to enhance the effect of other antiepileptic drugs.

Patent & exclusivity (US)

Per the FDA Orange Book (4 approved US products), the latest listed US patent on Stiripentol expires — and exclusivity 13 Jul 2029. Generic API sourcing typically opens up once these lapse.

Therapeutic areas